AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 112 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,286,319 | -44.3% | 515,097 | -3.1% | 0.00% | -50.0% |
| Q2 2023 | $5,895,921 | -21.4% | 531,643 | +8.8% | 0.00% | 0.0% |
| Q1 2023 | $7,499,964 | -27.1% | 488,597 | +5.3% | 0.00% | -33.3% |
| Q4 2022 | $10,292,121 | +67.1% | 463,818 | +23.0% | 0.00% | +50.0% |
| Q3 2022 | $6,159,000 | +25.6% | 377,118 | +11.7% | 0.00% | 0.0% |
| Q2 2022 | $4,904,000 | -11.4% | 337,479 | +12.6% | 0.00% | 0.0% |
| Q1 2022 | $5,538,000 | -20.0% | 299,802 | +2.9% | 0.00% | 0.0% |
| Q4 2021 | $6,926,000 | -0.8% | 291,341 | +2.8% | 0.00% | 0.0% |
| Q3 2021 | $6,979,000 | +97.5% | 283,351 | +98.2% | 0.00% | +100.0% |
| Q2 2021 | $3,533,000 | +12.7% | 142,959 | -0.5% | 0.00% | 0.0% |
| Q1 2021 | $3,135,000 | +11.8% | 143,705 | +30.9% | 0.00% | 0.0% |
| Q4 2020 | $2,803,000 | -7.7% | 109,803 | +1.8% | 0.00% | 0.0% |
| Q3 2020 | $3,037,000 | – | 107,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |